The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene
Abstract
Radiolabeled amino acid sequencing was used to characterize gp41, an antigen of HTLV-III/LAV, the virus believed to be the etiological agent of the acquired immune deficiency syndrome. This antigen is the one most commonly detected in immunoblot assays by sera of patients with AIDS or AIDS-related complex (ARC) and other individuals infected with HTLV-III/LAV. A mouse monoclonal antibody that was reactive with gp41 precipitated a 160-kilodalton protein (gp160) in addition to gp41, but did not precipitate a 120-kilodalton protein (gp120) from extracts of metabolically labeled cells producing HTLV-III. Extracts of infected cells that had been labeled with tritiated leucine or isoleucine were immunoprecipitated with the monoclonal antibody. The immunoprecipitates were fractionated by polyacrylamide gel electrophoresis and the p41 was eluted from the gel bands and subjected to amino-terminal radiolabeled amino acid sequencing by the semiautomated Edman degradation. Leucine residues occurred in cycles 7, 9, 12, 26, 33, and 34 among 40 cycles and isoleucine occurred in cycle 4 among 24 cycles analyzed. Comparison of the data with the deduced amino acid sequence of the env gene product of HTLV-III precisely placed gp41 in the COOH-terminal region of the env gene product. Gp160 is thus the primary env gene product and it is processed into gp120 and gp41.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Self-citationPopovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
Self-citationThe CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Self-citationSeiki, M., Hattori, S., Hirayama, Y., & Yoshida, M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3618 · Cited by 1,525
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS
Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M., & Oshiro, L. S. (1984) · Science · doi:10.1126/science.6206563 · Cited by 1,436
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Cited by
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
Isolation of a New Human Retrovirus from West African Patients with AIDS
Clavel, F., Guétard, D., Brun-Vézinet, F., Chamaret, S., Rey, M.-A., Santos-Ferreira, M. O., Laurent, A. G., Dauguet, C., Katlama, C., Rouzioux, C., et al. (1986) · Science · doi:10.1126/science.2425430 · Cited by 1,306
Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 Molecule
McDougal, J. S., Kennedy, M. S., Sligh, J. M., Cort, S. P., Mawle, A., & Nicholson, J. K. A. (1986) · Science · doi:10.1126/science.3001934 · Cited by 989
Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1
Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, E., Dayton, A., Rosen, C., Haseltine, W., & Sodroski, J. (1987) · Science · doi:10.1126/science.3629244 · Cited by 848
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling
Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2005) · Journal of Molecular Recognition · doi:10.1002/jmr.747 · Cited by 847
Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., & Capon, D. J. (1987) · Cell · doi:10.1016/0092-8674(87)90524-1 · Cited by 828
Starcich, B. R., Hahn, B. H., Shaw, G. M., McNeely, P. D., Modrow, S., Wolf, H., Parks, E. S., Parks, W. P., Josephs, S. F., Gallo, R. C., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90778-6 · Cited by 767
Self-citationFeinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C., & Wong-Staal, F. (1986) · Cell · doi:10.1016/0092-8674(86)90062-0 · Cited by 669
Self-citationA second post-transcriptional trans-activator gene required for HTLV-III replication
Sodroski, J., Goh, W. C., Rosen, C., Dayton, A., Terwilliger, E., & Haseltine, W. (1986) · Nature · doi:10.1038/321412a0 · Cited by 631
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication
Dayton, A. (1986) · Cell · doi:10.1016/0092-8674(86)90017-6 · Cited by 621
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., & Putney, S. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6768 · Cited by 618
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Kosek, J. C., Reyes, G. R., & Weissman, I. L. (1988) · Cell · doi:10.1016/0092-8674(88)90487-4 · Cited by 610
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
Moore, J. P., McKeating, J. A., Weiss, R. A., & Sattentau, Q. J. (1990) · Science · doi:10.1126/science.2251501 · Cited by 576
Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV
di Marzo Veronese, F., Copeland, T. D., DeVico, A. L., Rahman, R., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1986) · Science · doi:10.1126/science.2418504 · Cited by 545
Self-citationFine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins
Gelderblom, H. R., Hausmann, E. H. S., Özel, M., Pauli, G., & Koch, M. A. (1987) · Virology · doi:10.1016/0042-6822(87)90449-1 · Cited by 521
Structure of an unliganded simian immunodeficiency virus gp120 core
Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C., & Harrison, S. C. (2005) · Nature · doi:10.1038/nature03327 · Cited by 520
Alizon, M., Wain-Hobson, S., Montagnier, L., & Sonigo, P. (1986) · Cell · doi:10.1016/0092-8674(86)90860-3 · Cited by 517
HIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Modrow, S., Hahn, B. H., Shaw, G. M., Gallo, R. C., Wong-Staal, F., & Wolf, H. (1987) · Journal of Virology · doi:10.1128/jvi.61.2.570-578.1987 · Cited by 441
Self-citationWilley, R. L., Bonifacino, J. S., Potts, B. J., Martin, M. A., & Klausner, R. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9580 · Cited by 428
Resnick, L., diMarzo-Veronese, F., Schüpbach, J., Tourtellotte, W. W., Ho, D. D., Müller, F., Shapshak, P., Vogt, M., Groopman, J. E., Markham, P. D., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512123132402 · Cited by 413
Self-citationStructures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
Kwong, P. D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (2000) · Structure · doi:10.1016/s0969-2126(00)00547-5 · Cited by 390
Siliciano, R. F., Lawton, T., Knall, C., Karr, R. W., Berman, P., Gregory, T., & Reinherz, E. L. (1988) · Cell · doi:10.1016/0092-8674(88)90078-5 · Cited by 369
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl, P. L., Doms, R. W., & Moss, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.648 · Cited by 359
Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope Glycoprotein
Lasky, L. A., Groopman, J. E., Fennie, C. W., Benz, P. M., Capon, D. J., Dowbenko, D. J., Nakamura, G. R., Nunes, W. M., Renz, M. E., & Berman, P. W. (1986) · Science · doi:10.1126/science.3014647 · Cited by 353
Alterations in T4 (CD4) Protein and mRNA Synthesis in Cells Infected with HIV
Hoxie, J. A., Alpers, J. D., Rackowski, J. L., Huebner, K., Haggarty, B. S., Cedarbaum, A. J., & Reed, J. C. (1986) · Science · doi:10.1126/science.3095925 · Cited by 340
Walker, B. D., Kowalski, M., Goh, W. C., Kozarsky, K., Krieger, M., Rosen, C., Rohrschneider, L., Haseltine, W. A., & Sodroski, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.8120 · Cited by 337
Lambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G., & Petteway, S. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2186 · Cited by 336
Primary Human T-Lymphotropic Virus Type III Infection
HO, D. D., SARNGADHARAN, M. G., RESNICK, L., DIMARZOVERONESE, F., ROTA, T. R., & HIRSCH, M. S. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-6-880 · Cited by 334
Self-citationHTLV-III/LAV-Neutralizing Antibodies to an E. coli -Produced Fragment of the Virus Envelope
Putney, S. D., Matthews, T. J., Robey, W. G., Lynn, D. L., Robert-Guroff, M., Mueller, W. T., Langlois, A. J., Ghrayeb, J., Petteway, S. R., Weinhold, K. J., et al. (1986) · Science · doi:10.1126/science.2431482 · Cited by 332
Self-citationEarl, P. L., Moss, B., & Doms, R. W. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.2047-2055.1991 · Cited by 327
Lightfoote, M. M., Coligan, J. E., Folks, T. M., Fauci, A. S., Martin, M. A., & Venkatesan, S. (1986) · Journal of Virology · doi:10.1128/jvi.60.2.771-775.1986 · Cited by 310
Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
Geisbert, T. W., Hensley, L. E., Gibb, T. R., Steele, K. E., Jaax, N. K., & Jahrling, P. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780021 · Cited by 302
Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS)
Kaplan, M. H., Sadick, N., Scott McNutt, N., Meltzer, M., Sarngadharan, M. G., & Pahwa, S. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70066-8 · Cited by 301
Self-citationHo, D. D., Sarngadharan, M. G., Hirsch, M. S., Schooley, R. T., Rota, T. R., Kennedy, R. C., Chanh, T. C., & Sato, V. L. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.2024-2028.1987 · Cited by 294
Self-citationNew Human T-Lymphotropic Retrovirus Related to Simian T-Lymphotropic Virus Type III (STLV-III AGM )
Kanki, P. J., Barin, F., M'Boup, S., Allan, J. S., Romet-Lemonne, J. L., Marlink, R., McLane, M. F., Lee, T.-H., Arbeille, B., Denis, F., et al. (1986) · Science · doi:10.1126/science.3006256 · Cited by 293
Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1
Pinter, A., Honnen, W. J., Tilley, S. A., Bona, C., Zaghouani, H., Gorny, M. K., & Zolla-Pazner, S. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2674-2679.1989 · Cited by 291
Yang, X., Lee, J., Mahony, E. M., Kwong, P. D., Wyatt, R., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4634-4642.2002 · Cited by 277
The Molecular Biology of Human Immunodeficiency Virus Type 1 Infection
Epstein, F. H., Epstein, F. H., & Greene, W. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240506 · Cited by 273
Darke, P. L., Nutt, R. F., Brady, S. F., Garsky, V. M., Ciccarone, T. M., Leu, C.-T., Lumma, P. K., Freidinger, R. M., Veber, D. F., & Sigal, I. S. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80839-8 · Cited by 268
Geyer, H., Holschbach, C., Hunsmann, G., & Schneider, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37849-9 · Cited by 267
Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24
Veronese, F. D., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.795-801.1988 · Cited by 203
Self-citationStein, B. S., & Engleman, E. G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39849-7 · Cited by 189
Metadata
- Authors
- Veronese, F. D., DeVico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G.
- Venue
- Science
- Published
- 1985-09-27
- Volume
- 229
- Issue
- 4720
- Pages
- 1402-1405
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2047472099
- Cited by
- 437
- References
- 29
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.